infection-prevention-2017-scientifictracks-abstracts

11 / 17

Page 29
Notes:
conferenceseries.com
Volume 5, Issue 7 (Suppl) J Infect Dis Ther, an open access journal
ISSN: 2332-0877 Infection Prevention 2017
December 14-15, 2017
December 14-15, 2017 | Rome, Italy
13th World Congress on
INFECTION PREVENTION AND CONTROL
Roadmap to zero tolerance of device healthcare associated infections
Waleed A Mazi
Directorate of Health Affairs, Taif- Kingdom of Saudi Arabia
Effective infection prevention and control programmes in hospitals are essential to prevent infections whenever possible.
Healthcare-associated infections (HAIs) are the most adverse event threatening hospital patient safety worldwide. Many
factors contribute to the risk of HAIs. Information resources are freely available from many national and international
professional health agencies. We observed reduction of device healthcare associated infections after introduced Society for
Healthcare Epidemiology of America (SHEA) /Infectious Diseases Society of America (IDSA) basic practice recommendations
in acute care hospital. To reduce and control of central line-associated bloodstream Infection (CLABSI), catheter associated
urinary tract infections (CAUTI) and ventilator associated pneumonia (VAP) in acute care hospital. A prospective study to
reduce HAIs was conducted in tertiary hospital in 2012. Criteria and incidence rate of CLABSI, CAUTI and VAP were defined
according to NHSN guidelines. Hand hygiene observation (HHO) was conducted using the WHO my five moments for hand
hygiene recommendations. Prevention measures were implemented using SHEA/IDSA basic practice guidelines. We observed
significantly reduction of CLABSI, CAUTI and VAP after implementation SHEA/IDSA practice guidelines. SHEA/IDSA basic
practice guidelines are effective infection prevention model. The strategic plan steps were successfully targeted the goals. It is
possible to achieve and maintain zero tolerance without any additional coast.
Biography
Waleed A Mazi is a Regional Director for Infection Prevention and Control, Taif – Saudi Arabia. He did his Philosophy of Medical Science, Clinical Microbiology,
Karolinska Institutet, and Stockholm, Sweden. He is Infection Prevention and Control Director, King Abdul Aziz Specialist Hospital – Taif, Saudi Arabia (2009-2012).
He has internationally published articles on prevention of central line –associated bloodstream infection, WHO- Hand Hygiene implementation program, prevention
sharp injuries in healthcare settings and molecular genotyping for epidemiological purposes. He has given poster and oral presentations in many international
conferences (2010-2015).
Waleed A Mazi, J Infect Dis Ther 2017, 5:7(Suppl)
DOI: 10.4172/2332-0877-C1-035